Meyer Handelman Company’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.25M Sell
19,467
-5,206
-21% -$342K 0.04% 150
2026
Q1
$1.76M Sell
24,673
-15
-0.1% -$1.18K 0.05% 135
2025
Q4
$2.02M Sell
24,688
-30
-0.1% -$2.34K 0.06% 132
2025
Q3
$1.86M Sell
24,718
-500
-2% -$37.3K 0.06% 134
2025
Q2
$1.87M Sell
25,218
-2,526
-9% -$176K 0.06% 134
2025
Q1
$2.24M Buy
27,744
+15
+0.1% +$1.29K 0.08% 129
2024
Q4
$2.17M Sell
27,729
-1,085
-4% -$92.2K 0.08% 130
2024
Q3
$2.7M Sell
28,814
-3,072
-10% -$258K 0.09% 123
2024
Q2
$2.48M Sell
31,886
-4,010
-11% -$327K 0.09% 126
2024
Q1
$3.26M Sell
35,896
-5,267
-13% -$438K 0.11% 116
2023
Q4
$3.18M Sell
41,163
-6,235
-13% -$437K 0.12% 115
2023
Q3
$3.22M Buy
47,398
+4,897
+12% +$356K 0.13% 117
2023
Q2
$3.45M Sell
42,501
-8,788
-17% -$701K 0.14% 114
2023
Q1
$4.21M Buy
+51,289
New +$3.66M 0.18% 105

Other funds holding GEHC

Meyer Handelman Company's GEHC Position: Q2 2026 in Review

Meyer Handelman Company reduced its GE HealthCare (GEHC) stake by 21% in Q2 2026, selling an estimated $342K and leaving 19,467 shares worth $1.25M. The position accounts for 0.04% of the portfolio, ranked #150.

Meyer Handelman Company first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $4.21M in Q1 2023. 1,226 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Meyer Handelman Company held 19,467 shares of GE HealthCare worth $1.25M as of Q2 2026.
  • Meyer Handelman Company sold 5,206 GE HealthCare shares in Q2 2026, an estimated $342K.
  • GE HealthCare made up 0.04% of Meyer Handelman Company's portfolio in Q2 2026, its #150 holding.
  • Meyer Handelman Company first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Meyer Handelman Company's GE HealthCare position peaked at $4.21M in Q1 2023.
  • 1,226 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Meyer Handelman Company's 13F filing for Q2 2026, filed 3 Aug 2026.